Error message

The page you requested does not exist. For your convenience, a search was performed using the query what we do special interest groups clinical ethics.

Page not found

You are here

Interactive Decision

At CBSSM, we perform the basic and applied scientific research that will improve health care policy and practice to benefit patients and their families, health care providers, third-party payers, policy makers, and the general public.  In our "Interactive Decision" web feature, we turn a recent research finding into an interactive decision that a patient or policy maker might face.  Read, decide, click—and see how your answers compare with our respondents.

PSA Screening & Medical Maximizing-Minimizing Preferences (Dec-18)

Impact of the Vaccine Adverse Event Reporting System on Vaccine Acceptance and Trust (Aug-17)

Patient understanding of blood test results (Feb-17)

Attitudes toward Return of Secondary Results in Genomic Sequencing (Sep-16)

Moral concerns and the willingness to donate to a research biobank (Jun-16)

Liver Transplant Organ Quality Decision Aid: Would you consider a less than perfect liver? (Jan-16)

Blocks, Ovals, or People Icons in Icon Array Risk Graphics? (Sept-15)

Getting ahead of illness: using metaphors to influence medical decision making (May-15)

 

-->

 

Thu, February 01, 2018

Breast cancer patients face complex decisions about their treatment. Sarah Hawley, Reshma Jagsi, and colleagues developed an interactive online tool to help patients understand their treatment options. In a study published in the Journal of Clinical Oncology, they found that patients using the interactive tool had higher knowledge and felt more informed about options and felt better prepared to make a treatment choice.

Funded by

Funding Years: 2016-2019

This project will examine behavioral economic strategies for decreasing the use of low-value clinical services as listed in the Choose Wisely campaign. The proposed intervention, Committing to Choose Wisely (CCW), will ask clinicians to commit to avoid low-value services and provide resources to support adherence to this commitment. The intervention, which extends across two large health systems, will generate quantitative data from clinical automated data and focused medical record review data to examine rates of order before and after the intervention, as well as qualitative data from surveys and semi-structured interviews of both clinicians and patients to determine the effects of the intervention on their decision-making and experiences.

PI(s): Jeffrey Kullgren

Co-I(s): Eve Kerr

Thu, December 08, 2011

The Risk Evaluation and Education for Alzheimer's disease Study (REVEAL) is a series of clinical trials taking place at U-M's School of Public Health, along with other sites including Harvard University, Howard University, and the University of Pennsylvania. An audio interview with Dr. J. Scott Roberts can be found in the press release.

PIHCD: Laura Sedig and Ray Hutchinson

Wed, December 09, 2015, 2:00pm
Location: 
B003E NCRC Building 16

Laura Sedig and Ray Hutchinson will present on a project to improve parental understanding of randomization and equipoise when deciding whether or not to participate in a pediatric oncology clinical trial after diagnosis.  Their intervention will be a graphic and/or multimedia depiction of the concepts of randomization and equipoise given to the parents before or after their consent discussion.

Fri, May 08, 2015

The article discusses three themes that allow for creating supportive health care systems: nudge choices, but preserve and promote clinical judgment; promote relationships and communication; and encourage low-tech, high-touch care.

 

PIHCD: Michele Gornick

Wed, June 29, 2016, 4:00pm
Location: 
B004E NCRC Building 16
Michele Gornick  will present a survey whose purpose is to improve the communication of genomic sequencing results, specifically findings displayed in a genomic sequencing results report prototype. The survey is part of a Quality Assurance and Quality Improvement project, targeted to medical oncologists in the state of Michigan who have an active license and a clinical practice.

Michael Fetters has been named a 2016 Fulbright Distinguished Chair in Social Sciences. He will spend five months in Beijing teaching and leading a joint research project with colleagues at Peking University Health Science Center (PUHSC), U-M's partner school in the Joint Institute for Translational and Clinical Research.

Read More.

PIHCD- Martha Dabis & Ray De Vries

Wed, April 26, 2017, 4:00pm
Location: 
NCRC bldg 16 B004E

Discussion: Initial Inquiry into testing "Workings of the Human Spirit" theory (by the Chaplaincy Research Consortium) - chaplaincy research in clinical settings, outpatient cancer care, using UCSF methodology "Spiritual Assessment and Intervention Model".

Wed, March 21, 2018

Reshma Jagsi and colleagues recently published an article in the Annals of Internal Medicine regarding the Doris Duke Charitable Foundation's Fund to Retain Clinical Scientists. The goal of this program is to promote greater gender equity in academic medicine.

Research Topics: 

Pages